期刊文献+

子宫内膜癌中Glut-1、C-erbB-2表达及其相互关系 被引量:1

Expression of Glut-1 and C-erbB-2 in Adenocarcinoma of endometrium and their relationship
下载PDF
导出
摘要 目的探讨C-erbB-2和葡萄糖转运蛋白1(Glut-1)在不典型增生子宫内膜和子宫内膜腺癌中的表达特点及其相互关系。方法应用免疫组织化学方法检测Glut-1、C-erbB-2在30例正常增生期子宫内膜、32例不典型增生子宫内膜和35例子宫内膜腺癌中的表达,并结合临床资料进行分析。结果Glut-1、C-erbB-2在各组中的阳性表达率增生期子宫内膜均为0,不典型增生组分别为46.9%和59.4%,子宫内膜腺癌组82.9%,74.3%;二者在各试验组间均有显著差异(P<0.005)。不典型增生组和子宫内膜腺癌组间差异有显著性(P<0.005)。Glut-1与C-erbB-2在各组的表达呈显著正相关关系(P<0.01)。结论Glut-1和C-erbB-2在子宫内膜腺癌的发生、发展中起着协同而独立的作用,对其进行联合检测有助于子宫内膜腺癌及癌前病变的早期诊断。 Objective Propose To study the expression of Glut-1 and C-erbB-2 in adenocarcinoma and atypical hyperplasia of endometrium and to explore their significance and correlation. Methods Immunohistocbemistry method(SP) was used to examine the expression of Glut-1 and C-erbB-2 in 30 cases of normal proliferative endometrium, 32 cases of atypical endometrial hyperplasia and 35 cases of endometrial adenocarcinoma. Their clinical data was observed. Results The expression of Glut-1 and C-erbB-2 had not been detected in normal proliferative endemetrium, the expression rate was 46.9 % and 59.4 % in atypical endometrial hyperplasia, 82.9 % and 74.3 % in endometrial adenocarcinoma. There were significant differences among normal proliferative endometrium, atypical hyperplasia and adenocarcinoma of endometrium. The difference between atypical hyperplasia and adenocarcinoma of endomemun were statistically significant. Positive correlation was also found between Glut- 1 and C-erbB-2 expression( P 〈0. 01 ). Conclusion Glut-1 and C-erbB-2 may play certain role in oncogenesis and progression of endometrial adenocarcinoma to different extent. Detection of Glut-1 together with C-erbB-2 is valuable for early diagnosis of adenocarcinoma and precancerous lesion.
作者 张颖 陈海玲
出处 《中国实验诊断学》 北大核心 2009年第11期1555-1557,共3页 Chinese Journal of Laboratory Diagnosis
关键词 子宫内膜腺癌 GLUT-1 C—erbB.2 免疫组织化学 Endometrial Adenocarcinoma Glut- 1 C- erbB-2 Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献18

  • 1Shih JC,Cheng SH.Identification of serotonin-binding proteins using a photoaffinity labeling probe[J].Adv Exp Med Biol,1981,1339(1):319.
  • 2K Semba,N Kamata,K Toyoshima,et al.A v-erbB-related protooncogene,c-erbB-2,is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma[J].Proc Natl Acad Sci USA,1985,82(19):6497.
  • 3Placido SD,Carlomagno C,Laurentiis MD.C-erbB2 expression predicts tamoxifen efficacy in breast cancer patients[J].Breast Cancer Res Treat,1998,52(1~3):55.
  • 4O'Malley FP,Saad Z,Kerkvliet N,et al.The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer[J].Hum Pathol,1996,27(9):955.
  • 5Nichols DW,Wolff DJ,Self S,etal.A testing algothrim for determination of HER2 status in patients with breast cancer[J].Ann Clin Lab Sci,2002,32(1):3.
  • 6Nunes RA,Harris LN.The HER2 extracellular domain as a prognostic and predictive factor in breast cancer[J].Clin Breast Cancer,2002,3(2):125.
  • 7Jimenez P,Canton J,Concha A,et al.Microsatelite instability analysis in tumors with different mechanisms for total loss of HLA expression[J].Cancer Immunol Immunother,2000,48(12):684.
  • 8Loukas K.Loss of transporter in antigen processing Ⅰ transport protein and major histocompatibility complex class Ⅰ molecules in metastatic versus primary breast cancer[J].Cancer Res,1995,55(22):5191.
  • 9Willemien JVD,Tjiong MY,Himders CGJM,et al.Association of allele-spefic HLA expression and histopathologic progression of cervical carcinoma[J].Gynecol Oncol,1996,62(1):33.
  • 10Younes M,Lechago LV,Somoano JR,et al.Wide expression of the human erythrocyte glucose transpoter GLUT1 in human cancers[J].Cancer Res,1996,56(5):1164-1167.

共引文献7

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部